Exploring the Regulatory Mechanism of Total Alkaloids from Portulaca oleracea L. in UC Treatment Based on Network Pharmacology
International Journal of Molecular Sciences · 20.07.2025 · 26 (14) · 6978
DOI: 10.3390/ijms26146978 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.07.2025. Verfasst von Tianci Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical Technical, Beihua University, Jilin 132013, China. Hauptthemen laut MEDLINE: Portulaca, Alkaloids, Network Pharmacology, Colitis, Ulcerative. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jilin Province Science and Technology Development Plan Project.
Abstract (Originalsprache)
This study aimed to investigate the potential mechanisms of action of total alkaloids from Portulaca oleracea L. (POL) on ulcerative colitis (UC) using a network pharmacology approach. Network pharmacology analysis identified two bioactive alkaloids within POL as primary anti-UC constituents, targeting 16 core therapeutic proteins and 113 UC-associated signaling pathways. To further explore the therapeutic effects, in vitro cell assays and in vivo animal experiments were conducted. In vitro, high concentrations of Portulaca oleracea total alkaloids (POAs) demonstrated dose-dependent cytotoxicity, significantly reducing Caco-2 cell viability and impairing migration. In a murine model of UC, disease induction led to substantial weight loss, elevated disease activity index (DAI) scores, colon shortening, and severe colonic tissue damage compared to controls. Furthermore, the UC group displayed significantly upregulated serum levels of pro-inflammatory cytokines, TNF-α and IL-1β, as well as increased protein and mRNA expression of TLR4 and NF-κB in colon tissues. Crucially, POAs treatment effectively ameliorated UC symptoms in mice, significantly reducing DAI scores, mitigating colon shortening, and markedly suppressing TLR4/NF-κB pathway activation. These findings strongly suggest that the therapeutic effects of POAs in UC are, at least in part, mediated by the inhibition of the TLR4/NF-κB signaling pathway, leading to a reduction in colonic inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical Technical, Beihua University, Jilin 132013, China.
- School of Laboratory Medicine, Beihua University, Jilin 132013, China.
ORCID-Profile: Jinxia Ai
Förderung
- Jilin Province Science and Technology Development Plan Project
Zitieren
APA
Zhang, T., Gao, L., Wang, Q., Zheng, J., Wang, X., Jiang, M., Wu, K., & Ai, J. (2025). Exploring the Regulatory Mechanism of Total Alkaloids from Portulaca oleracea L. in UC Treatment Based on Network Pharmacology. International Journal of Molecular Sciences, 26(14), 6978. https://doi.org/10.3390/ijms26146978
Vancouver
Zhang T, Gao L, Wang Q, Zheng J, Wang X, Jiang M, et al. Exploring the Regulatory Mechanism of Total Alkaloids from Portulaca oleracea L. in UC Treatment Based on Network Pharmacology. International Journal of Molecular Sciences. 2025;26(14):6978. doi:10.3390/ijms26146978
BibTeX
@article{Zhang2025,
author = {Zhang, Tianci and Gao, Linran and Wang, Qianying and Zheng, Jiahui and Wang, Xinyu and Jiang, Meng and Wu, Kaixin and Ai, Jinxia},
title = {Exploring the Regulatory Mechanism of Total Alkaloids from Portulaca oleracea L. in UC Treatment Based on Network Pharmacology},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {14},
pages = {6978},
doi = {10.3390/ijms26146978}
}
EUVIMED